New York State Common Retirement Fund
ZBIO

New York State Common Retirement Fund’s Zenas BioPharma ZBIO Stock Holding History

New York State Common Retirement Fund’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Buy
10,300
+4,100
+66% +$81.5K ﹤0.01% 2258
2026
Q1 		$121K Hold
6,200
– – ﹤0.01% 2442
2025
Q4 		$225K Hold
6,200
– – ﹤0.01% 2246
2025
Q3 		$138K Hold
6,200
– – ﹤0.01% 2463
2025
Q2 		$60.1K Hold
6,200
– – ﹤0.01% 2888
2025
Q1 		$49K Buy
+6,200
New +$48.5K ﹤0.01% 2783

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

New York State Common Retirement Fund's ZBIO Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Zenas BioPharma (ZBIO) stake by 66% in Q2 2026, buying an estimated $81.5K and bringing the position to 10,300 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

New York State Common Retirement Fund first reported a position in ZBIO in Q1 2025 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • New York State Common Retirement Fund held 10,300 shares of Zenas BioPharma worth $261K as of Q2 2026.
  • New York State Common Retirement Fund bought 4,100 Zenas BioPharma shares in Q2 2026, an estimated $81.5K.
  • Zenas BioPharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2258 holding.
  • New York State Common Retirement Fund first reported a position in Zenas BioPharma in Q1 2025 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.